Publikationen

 Dr. med. Michael Amann 

Chiang CH, Chiang CH, Pickering JW, Stoyanov KM, Chew DP, Neumann JT, Ojeda F, Sörensen NA, Su KY, Kavsak P, Worster A, Inoue K, Johanessen TR, Atar D, Amann M, Hochholzer W, Mokhtari A, Ekelund, U, Twerenbold R, Mueller C, Bahrmann P, Buttinger N, Dooley M, Ruangsomboon O, Nowak RM, DeFilippi CR, Peacock WF, Neilan TG, Liu MA, Hsu WT, Lee GH, Tang PU, Ma KSK, Westermann D, Blankenberg S, Giannitsis E,  Than MP, Lee CC. Performance of the european society of cardiology 0/1-hour, 0/2-hour, and 0/3-hour algorithms for rapid triage of acute myocardial infarction: An international collaborative meta-analysis. Ann Intern Med. 2022 Jan;175(1):101-113.

Dees D, Rahimi F, Amann M, Nührenberg TG, Löffelhardt N, Schmitz R, Valina CM, Neumann FJ, Hochholzer W. Prevalence and causes of myocardial infarction with non-obstructive coronary srteries in a contemporary cohort of patients with suspected myocardial infarction. J Clin Med. 2021 Nov 6;10(21):5188.

Amann M, Gaiser F, Schwenk SI, Rahimi F, Schmitz R, Mashayekhi K, Ferenc M, Neumann FJ, Valina CM, Hochholzer W. Evaluation of a 1-hour troponin algorithm for diagnosing myocardial infarction in high-risk patients admitted to a chest pain unit: the prospective FAST-MI cohort study. BMJ Open. 2019 Nov 7;9 (11).

Valina CM, Merz S, Löffelhardt N, Amann M, Ferenc M, Stratz C, Neumann FJ, Hochholzer W. Risk of discontinuation of clopidogrel after 1 month following bare-metal stents: a propensity-score adjusted comparison with continued administration of clopidogrel after drug-eluting stents. J Thromb Thrombolysis. 2018 Apr;45(3):432-439. 

Bömicke T, Valina CM, Stratz C, Amann M, Neumann FJ, Hochholzer W. Onclopidogrel platelet reactivity as predictor for long-term clinical outcome inpatients after planned discontinuation of clopidogrel. Thromb Haemost. 2017 Jul 26;117(8):1644-1650. 

Hochholzer W, Kleiner P, Younas I, Valina CM, Löffelhardt N, Amann M, Bömicke T, Ferenc M, Hauschke D, Trenk D, Neumann FJ, Stratz C. Randomized Comparison of Oral P2Y12-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor: The ExcelsiorLOAD2 Trial. JACC Cardiovasc Interv. 2017 Jan 23;10(2):121-129.

Stratz C, Nührenberg T, Amann M, Cederqvist M, Kleiner P, Valina CM, Trenk D, Neumann FJ, Hochholzer W. Impact of reticulated platelets on antiplatelet response to thienopyridines is independent of platelet turnover. Thromb Haemost. 2016 Oct 28;116(5):941-948. 

Stratz C, Bömicke T, Younas I, Kittel A, Amann M, Valina CM, Nührenberg T, Trenk D, Neumann FJ, Hochholzer W. Comparison of Immature Platelet Count to Established Predictors of Platelet Reactivity During Thienopyridine Therapy. J Am Coll Cardiol. 2016 Jul 19;68(3):286-293. 

Valina CM, Amann M, Stratz C, Trenk D, Löffelhardt N, Ferenc M, Neumann FJ, Hochholzer W. Predictors of high-sensitivity cardiac troponin in stable patients undergoing coronary angiography. EuroIntervention. 2016 Jun 20;12(3):329-36.

Amann M, Ferenc M, Valina CM, Bömicke T, Stratz C, Leggewie S, Trenk D, Neumann FJ, Hochholzer W. Validation of a P2Y12-receptor specific whole blood platelet aggregation assay. Platelets. 2016 Nov;27(7):668-672. 

Hochholzer W, Amann M, Titov A, Younas I, Löffelhardt N, Riede F, Potocnik C, Stratz C, Hauschke D, Trenk D, Neumann FJ, Valina CM. Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention: The ExcelsiorLOAD Trial. JACC Cardiovasc Interv. 2016 Feb 8;9(3):219-227.

Nührenberg TG, Zhao M, Stratz C, Amann M, Valina CM, Gick M, Trenk D, Binder H, Büttner HJ, Neumann FJ. Large platelets but not putative endothelial progenitor cells are associated with low strut coverage after drug-eluting stent implantation. Int J Cardiol. 2015 Nov 15;199:358-65. 

Hochholzer W, Valina CM, Bömicke T, Amann M, Stratz C, Nührenberg T, Trenk D, Neumann FJ. Intrinsic platelet reactivity before start with clopidogrel as predictor for on-clopidogrel platelet function and long-term clinical outcome. Thromb Haemost. 2015 Jul;114(1):109-14. 

Hochholzer W, Valina CM, Stratz C, Amann M, Schlittenhardt D, Büttner HJ, Trenk D, Neumann FJ. High-sensitivity cardiac troponin for risk prediction in patients with and without coronary heart disease. Int J Cardiol. 2014 Sep 20;176(2):444-9. 

Stratz C, Nührenberg T, Fiebich BL, Amann M, Kumar A, Binder H, Hoffmann I, Valina C, Hochholzer W, Trenk D, Neumann FJ. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients. Thromb Haemost. 2014 May 5;111(5):902-11. 

Nührenberg TG, Trenk D, Leggewie S, Ristau I, Amann M, Stratz C, Hochholzer W, Valina CM, Neumann FJ. Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study. Platelets. 2013;24(7):549-53. 

Amann M, Modabber A, Burghardt J, Stratz C, Falch C, Buess GF, Kirschniak A. Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 lowrisk carcinomas. World J Surg Oncol. 2012 Nov 26;10:255. 

Stratz C, Amann M, Berg DD, Morrow DA, Neumann FJ, Hochholzer W. Novel biomarkers in cardiovascular disease: research tools or ready for personalized medicine? Cardiol Rev. 2012 May-Jun;20(3):111-7.